Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Dexamethasone
×
Thoracic
×
Clear all
Filters
3
NCT06788912
2026-03-10
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2
Recruiting
60 enrolled
NCT03950674
2024-06-10
MK-3475-189
Merck Sharp & Dohme LLC
Phase 3
Completed
40 enrolled
20 charts